Literature DB >> 29418038

Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer.

F Moro1, G Magoga2, T Pasciuto1, F Mascilini1, M C Moruzzi1, D Fischerova3, L Savelli4, S Giunchi4, R Mancari5, D Franchi5, A Czekierdowski6, W Froyman7, D Verri8, E Epstein9, V Chiappa10, S Guerriero11, G F Zannoni12, D Timmerman7, G Scambia1, L Valentin13, A C Testa2.   

Abstract

OBJECTIVE: To describe the clinical and ultrasound characteristics of ovarian pure endometrioid carcinomas.
METHODS: This was a retrospective multicenter study of patients with a histological diagnosis of pure endometrioid carcinoma. We identified 161 patients from the International Ovarian Tumor Analysis (IOTA) database who had undergone preoperative ultrasound examination by an experienced ultrasound examiner between 1999 and 2016, and another 78 patients from the databases of the departments of gynecological oncology in the participating centers. All tumors were described using IOTA terminology. In addition, one author reviewed all available ultrasound images and described them using pattern recognition.
RESULTS: Median age of the 239 patients was 55 years (range, 19-88 years). On ultrasound examination, two (0.8%) endometrioid carcinomas were described as unilocular cysts, three (1.3%) as multilocular cysts, 37 (15.5%) as unilocular-solid cysts, 115 (48.1%) as multilocular-solid cysts and 82 (34.3%) as solid masses. Median largest tumor diameter was 102.5 mm (range, 20-300 mm) and median largest diameter of the largest solid component was 63 mm (range, 9-300 mm). Papillary projections were present in 70 (29.3%) masses. Most cancers (188 (78.7%)) were unilateral. In 49 (20.5%) cases, the cancer was judged by the pathologist to develop from endometriosis. These cancers, compared with those without evidence of tumor developing from endometriosis, more often manifested papillary projections on ultrasound (46.9% (23/49) vs 24.7% (47/190)), were less often bilateral (8.2% (4/49) vs 24.7% (47/190)) and less often associated with ascites (6.1% (3/49) vs 28.4% (54/190)) and fluid in the pouch of Douglas (24.5% (12/49) vs 48.9% (93/190)). Retrospective analysis of available ultrasound images using pattern recognition revealed that many tumors without evidence of tumor developing from endometriosis (36.3% (41/113)) had a large central solid component entrapped within locules, giving the tumor a cockade-like appearance.
CONCLUSIONS: Endometrioid cancers are usually large, unilateral, multilocular-solid or solid tumors. The ultrasound characteristics of endometrioid carcinomas developing from endometriosis differ from those without evidence of tumor developing from endometriosis, the former being more often unilateral cysts with papillary projections and no ascites.
Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endometrioid ovarian carcinoma; ovarian neoplasms; ultrasonography

Mesh:

Year:  2018        PMID: 29418038     DOI: 10.1002/uog.19026

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  7 in total

1.  The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy.

Authors:  Shoichiro Yamanaka; Naoki Kawahara; Ryuji Kawaguchi; Keita Waki; Tomoka Maehana; Yosuke Fukui; Ryuta Miyake; Yuki Yamada; Hiroshi Kobayashi; Fuminori Kimura
Journal:  Diagnostics (Basel)       Date:  2022-05-12

Review 2.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 3.  Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

Authors:  Francesca Moro; Rosanna Esposito; Chiara Landolfo; Wouter Froyman; Dirk Timmerman; Tom Bourne; Giovanni Scambia; Lil Valentin; Antonia Carla Testa
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

4.  Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family.

Authors:  Ying Liao; Chunhua Tu; Xiaoxia Song; Liping Cai
Journal:  J Assist Reprod Genet       Date:  2020-04-30       Impact factor: 3.412

5.  Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma.

Authors:  Hiroki Shinmura; Koichi Yoneyama; Eika Harigane; Yohei Tsunoda; Takehiko Fukami; Takashi Matsushima; Toshiyuki Takeshita
Journal:  Int J Gynecol Cancer       Date:  2020-04-30       Impact factor: 3.437

Review 6.  Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.

Authors:  Eleftherios P Samartzis; S Intidhar Labidi-Galy; Michele Moschetta; Mario Uccello; Dimitrios R Kalaitzopoulos; J Alejandro Perez-Fidalgo; Stergios Boussios
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.